ArticleVaccines2025

Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies.

Mario Ferraioli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.